Related references
Note: Only part of the references are listed.Single cannabidiol administration affects anxiety-, obsessive compulsive-, object memory-, and attention-like behaviors in mice in a sex and concentration dependent manner
Carley Marie Huffstetler et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2023)
Cannabidiol attenuates fear memory expression in female rats via hippocampal 5-HT1A but not CB1 or CB2 receptors
Jaqueline M. Franzen et al.
NEUROPHARMACOLOGY (2023)
Anxiolytic effects of endocannabinoid enhancing compounds: A systematic review and meta-analysis
Caroline M. B. Kwee et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2023)
Symptom fluctuation over the menstrual cycle in anxiety disorders, PTSD, and OCD: a systematic review
Saria Adele Green et al.
ARCHIVES OF WOMENS MENTAL HEALTH (2022)
Effects of cannabidiol and Δ9-tetrahydrocannabinol in the elevated plus maze in mice
Junhan Liu et al.
BEHAVIOURAL PHARMACOLOGY (2022)
What's wrong with my experiment?: The impact of hidden variables on neuropsychopharmacology research
Hanna M. Butler-Struben et al.
NEUROPSYCHOPHARMACOLOGY (2022)
Psychiatric Symptoms Across the Menstrual Cycle in Adult Women: A Comprehensive Review
Ariel B. Handy et al.
HARVARD REVIEW OF PSYCHIATRY (2022)
Cannabinoid CB1 Receptor Involvement in the Actions of CBD on Anxiety and Coping Behaviors in Mice
Amaya Austrich-Olivares et al.
PHARMACEUTICALS (2022)
Impact of the mouse estrus cycle on cannabinoid receptor agonist-induced molecular and behavioral outcomes
Hye Ji J. Kim et al.
PHARMACOLOGY RESEARCH & PERSPECTIVES (2022)
Adverse Effects of Oral Cannabidiol: An Updated Systematic Review of Randomized Controlled Trials (2020-2022)
Jose Diogo R. Souza et al.
PHARMACEUTICS (2022)
Commonly-used rodent tests of anxiety-like behavior lack predictive validity for human sex differences
Stina Borchers et al.
PSYCHONEUROENDOCRINOLOGY (2022)
Sex-dependent differences in the anxiolytic-like effect of cannabidiol in the elevated plus-maze
Debora Fabris et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2022)
Cannabidiol ameliorates the anxiogenic and compulsive-like behaviors induced by chronic consumption of a high-carbohydrate diet in male mice
Anna Paula Marcal et al.
METABOLIC BRAIN DISEASE (2022)
What Pre-clinical Rat Models Can Tell Us About Anxiety Across the Menstrual Cycle in Healthy and Clinically Anxious Humans
Jodie E. Pestana et al.
CURRENT PSYCHIATRY REPORTS (2022)
Premenstrual exacerbation of mental health disorders: a systematic review of prospective studies
Louise Nora Nolan et al.
ARCHIVES OF WOMENS MENTAL HEALTH (2022)
The Impact of the Menstrual Cycle and Underlying Hormones in Anxiety and PTSD: What Do We Know and Where Do We Go From Here?
Yael Nillni et al.
CURRENT PSYCHIATRY REPORTS (2021)
Enhanced responsiveness to hypoxic panicogenic challenge in female rats in late diestrus is suppressed by short-term, low-dose fluoxetine: Involvement of the dorsal raphe nucleus and the dorsal periaqueductal gray
Matheus F. Batistela et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2021)
Cannabidiol as a Potential Treatment for Anxiety and Mood Disorders: Molecular Targets and Epigenetic Insights from Preclinical Research
Philippe A. Melas et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Glial Cells and Their Contribution to the Mechanisms of Action of Cannabidiol in Neuropsychiatric Disorders
Franciele F. Scarante et al.
FRONTIERS IN PHARMACOLOGY (2021)
Female but not male rats show biphasic effects of low doses of Δ9 -tetrahydrocannabinol on anxiety: can cannabidiol interfere with these effects?
Beatriz Zanutto Salviato et al.
NEUROPHARMACOLOGY (2021)
Endocannabinoids, cannabinoids and the regulation of anxiety
Gavin N. Petrie et al.
NEUROPHARMACOLOGY (2021)
Effect of Estrous Cycle on Behavior of Females in Rodent Tests of Anxiety
Thelma A. Lovick et al.
FRONTIERS IN PSYCHIATRY (2021)
Levelling the Translational Gap for Animal to Human Efficacy Data
Guilherme S. Ferreira et al.
ANIMALS (2020)
Cannabidiol: A Potential New Alternative for the Treatment of Anxiety, Depression, and Psychotic Disorders
Maria S. Garcia-Gutierrez et al.
BIOMOLECULES (2020)
Diversity of molecular targets and signaling pathways for CBD
Douglas L. de Almeida et al.
PHARMACOLOGY RESEARCH & PERSPECTIVES (2020)
Molecular Targets of Cannabidiol in Experimental Models of Neurological Disease
Serena Silvestro et al.
MOLECULES (2020)
Use of Cannabidiol for the Treatment of Anxiety: A Short Synthesis of Pre-Clinical and Clinical Evidence
Madison Wright et al.
CANNABIS AND CANNABINOID RESEARCH (2020)
Acute Cannabinoids Produce Robust Anxiety-Like and Locomotor Effects in Mice, but Long-Term Consequences Are Age- and Sex-Dependent
Chelsea R. Kasten et al.
FRONTIERS IN BEHAVIORAL NEUROSCIENCE (2019)
Short-term, low-dose fluoxetine prevents oestrous cycle-linked increase in anxiety-like behaviour in female rats
Rebeca Machado Figueiredo et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2019)
Cannabidiol (CBD) reduces anxiety-related behavior in mice via an FMRP-independent mechanism
Jerzy Zieba et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2019)
Cannabidiol presents an inverted U-shaped dose-response curve in a simulated public speaking test
Ila M. Linares et al.
BRAZILIAN JOURNAL OF PSYCHIATRY (2019)
The anxiolytic effects of cannabidiol in chronically stressed mice are mediated by the endocannabinoid system: Role of neurogenesis and dendritic remodeling
Manoela V. Fogaca et al.
NEUROPHARMACOLOGY (2018)
Panic-like escape response elicited in mice by exposure to CO2, but not hypoxia
Ailton Spiacci et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2018)
Cannabidiol skews biased agonism at cannabinoid CB1 and CB2 receptors with smaller effect in CB1-CB2 heteroreceptor complexes
Gemma Navarro et al.
BIOCHEMICAL PHARMACOLOGY (2018)
Translational Investigation of the Therapeutic Potential of Cannabidiol (CBD): Toward a New Age
Jose A. Crippa et al.
FRONTIERS IN IMMUNOLOGY (2018)
Dose translation between laboratory animals and human in preclinical and clinical phases of drug development
Anroop Nair et al.
DRUG DEVELOPMENT RESEARCH (2018)
The endocannabinoid system as a target for novel anxiolytic drugs
Sachin Patel et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2017)
Influence of estrous cycle hormonal fluctuations and gonadal hormones on the ventilatory response to hypoxia in female rats
Danuzia A. Marques et al.
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2017)
The direct actions of cannabidiol and 2-arachidonoyl glycerol at GABAA receptors
T. Bakas et al.
PHARMACOLOGICAL RESEARCH (2017)
Effect of prior foot shock stress and Δ9-tetrahydrocannabinol, cannabidiolic acid, and cannabidiol on anxiety-like responding in the light-dark emergence test in rats
Erin M. Rock et al.
PSYCHOPHARMACOLOGY (2017)
Inverted U-Shaped Dose-Response Curve of the Anxiolytic Effect of Cannabidiol during Public Speaking in Real Life
Antonio W. Zuardi et al.
Frontiers in Pharmacology (2017)
An Update on Safety and Side Effects of Cannabidiol: A Review of Clinical Data and Relevant Animal Studies
Kerstin Iffland et al.
CANNABIS AND CANNABINOID RESEARCH (2017)
Influence of single and repeated cannabidiol administration on emotional behavior and markers of cell proliferation and neurogenesis in non-stressed mice
Angelica Pupin Schiavon et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2016)
CO2 exposure as translational cross-species experimental model for panic
N. K. Leibold et al.
TRANSLATIONAL PSYCHIATRY (2016)
Effects of intra-infralimbic prefrontal cortex injections of cannabidiol in the modulation of emotional behaviors in rats: Contribution of 5HT1A receptors and stressful experiences
A. L. Z. Marinho et al.
BEHAVIOURAL BRAIN RESEARCH (2015)
Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor
R. B. Laprairie et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
Elevation of brain allopregnanolone rather than 5-HT release by short term, low dose fluoxetine treatment prevents the estrous cycle-linked increase in stress sensitivity in female rats
Adam J. Devall et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2015)
SEROTONIN IN THE DORSAL PERIAQUEDUCTAL GRAY INHIBITS PANIC-LIKE DEFENSIVE BEHAVIORS IN RATS EXPOSED TO ACUTE HYPOXIA
A. Spiacci et al.
NEUROSCIENCE (2015)
Molecular Targets of Cannabidiol in Neurological Disorders
Clementino Ibeas Bih et al.
NEUROTHERAPEUTICS (2015)
Sex differences in anxiety and depression clinical perspectives
Margaret Altemus et al.
FRONTIERS IN NEUROENDOCRINOLOGY (2014)
The anxiolytic effect of cannabidiol on chronically stressed mice depends on hippocampal neurogenesis: involvement of the endocannabinoid system
Alline C. Campos et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2013)
The role of 5-HT1A receptors in the anti-aversive effects of cannabidiol on panic attack-like behaviors evoked in the presence of the wild snake Epicrates cenchria crassus (Reptilia, Boidae)
Andre Twardowschy et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2013)
Involvement of serotonin-mediated neurotransmission in the dorsal periaqueductal gray matter on cannabidiol chronic effects in panic-like responses in rats
Alline Cristina Campos et al.
PSYCHOPHARMACOLOGY (2013)
The role of menstrual cycle phase and anxiety sensitivity in catastrophic misinterpretation of physical symptoms during a CO2 challenge
Yael I. Nillni et al.
ARCHIVES OF WOMENS MENTAL HEALTH (2012)
Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders
Alline Cristina Campos et al.
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2012)
Plasma and brain pharmacokinetic profile of cannabidiol (CBD), cannabidivarine (CBDV), Δ9-tetrahydrocannabivarin (THCV) and cannabigerol (CBG) in rats and mice following oral and intraperitoneal administration and CBD action on obsessive-compulsive behaviour
Serena Deiana et al.
PSYCHOPHARMACOLOGY (2012)
Gender differences in anxiety disorders: Prevalence, course of illness, comorbidity and burden of illness
Carmen P. McLean et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2011)
Cannabidiol Reduces the Anxiety Induced by Simulated Public Speaking in Treatment-Naive Social Phobia Patients
Mateus M. Bergamaschi et al.
NEUROPSYCHOPHARMACOLOGY (2011)
Intra-dorsal periaqueductal gray administration of cannabidiol blocks panic-like response by activating 5-HT1A receptors
Vanessa de Paula Soares et al.
BEHAVIOURAL BRAIN RESEARCH (2010)
Antidepressant-like effects of cannabidiol in mice: possible involvement of 5-HT1A receptors
T. V. Zanelati et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Involvement of 5HT1A receptors in the anxiolytic-like effects of cannabidiol injected into the dorsolateral periaqueductal gray of rats
Alline Cristina Campos et al.
PSYCHOPHARMACOLOGY (2008)
Neuronal excitability in the periaqueductal grey matter during the estrous cycle in female Wistar rats
K. E. Brack et al.
NEUROSCIENCE (2007)
Behavioral and cardiovascular effects of 7.5% CO2 in human volunteers
JE Bailey et al.
DEPRESSION AND ANXIETY (2005)
Cannabidiol: An overview of some pharmacological aspects
R Mechoulam et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2002)